Informations générales (source: ClinicalTrials.gov)
Modification of Cortical Activation After Luminous Stimulation in Functional Magnetic Resonance Imaging (MRI) in Patients With Photophobia Related to Moderate to Acute Dry Eye Syndrome.
Interventional
N/A
University Hospital, Toulouse (Voir sur ClinicalTrials)
mars 2018
mars 2019
29 juin 2024
Photophobia is a common and disabling symptom in patient with dry eye syndrome. The aim
of this study is tried to better understand this complain analyzing brain activation
during a luminous stimulation to highlight modification of cortical activation.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
University Hospital Toulouse - 31059 - Toulouse - France | François Malecaze, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Symptomatic subjects : presence of bilateral photophobia with an impact on daily
activities (driving, outdoor activities, screens use, socio-professional
activities...) in a context of patent dry eye syndrome
- Asymptomatic subjects : no dry eye syndrome and no photophobia
- Patients able to understand medical information and sign consent.
- Symptomatic subjects : presence of bilateral photophobia with an impact on daily
activities (driving, outdoor activities, screens use, socio-professional
activities...) in a context of patent dry eye syndrome
- Asymptomatic subjects : no dry eye syndrome and no photophobia
- Patients able to understand medical information and sign consent.
- Ophthalmological pathologies of cornea, iris, optic nerve or retina
- MRI contraindications (metallic prosthesis, pacemaker, claustrophobia)
- Neurological pathology which may affect MRI results
- Subjects under legal protection